Cargando…
A pilot study to determine the occurrence of concomitant diseases and drug intake in patients on antituberculosis therapy
INTRODUCTION: Altered pharmacokinetics of antituberculosis (anti-TB) drugs due to interaction with non-TB medications or concomitant diseases may lead to suboptimal plasma levels of the affected drugs and hence contribute to the emergence of drug resistance in mycobacteria. Yet, few studies have inv...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060940/ https://www.ncbi.nlm.nih.gov/pubmed/30090786 http://dx.doi.org/10.4103/jfmpc.jfmpc_103_17 |